Latest intangible assets for 600201.SS: $660M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), 600201.SS shows a intangible assets of $660M. That compares with $610M in the prior-year period — up 7.6% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 600201.SS's intangible assets is now $660M (was $610M) — a 7.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Jinyu Bio-technology , Ltd. is outperforming or lagging.
Tracking 600201.SS's intangible assets over time shows whether Jinyu Bio-technology , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $660M That compares with $610M in the prior-year period — up 7.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this intangible assets page, Stockcircle has Jinyu Bio-technology , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $660M) with ownership activity and broader fundamentals.
Jinyu Bio-technology , Ltd.'s intangible assets is $660M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.